Home / Recalls / FARMAKEIO OUTSOURCING LLC / D-0130-2026

D-0130-2026 Class II Ongoing

Recalled by FARMAKEIO OUTSOURCING LLC — Southlake, TX

Recall Details

Product Type
Drugs
Report Date
November 5, 2025
Initiation Date
October 14, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
18,124 pellets

Product Description

Testosterone / Triamcinolone Acetonide, 12.5MG/2.5MCG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0363-01

Reason for Recall

CGMP Deviations: Potential presence of metal particulate matter

Distribution Pattern

Nationwide in the USA and Antigua

Code Information

Lot# 3171, 3172, Exp 2/11/2026

Other recalls by FARMAKEIO OUTSOURCING LLC

  • D-0129-2026 Class II — Testosterone Regular Release 200 MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTI (October 14, 2025)
  • D-0125-2026 Class II — Testosterone 62.5 MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, Fa (October 14, 2025)
  • D-0123-2026 Class II — Testosterone 25MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, Farma (October 14, 2025)
  • D-0135-2026 Class II — Testosterone / Triamcinolone Acetonide 87.5MG/17.5MCG, 1 PELLET (STERILE) FOR SU (October 14, 2025)
  • D-0124-2026 Class II — Testosterone 50MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, Farma (October 14, 2025)
  • D-0133-2026 Class II — Testosterone / Triamcinolone Acetonide 50MG/10MCG, 1 PELLET (STERILE) FOR SUBCUT (October 14, 2025)
  • D-0136-2026 Class II — Testosterone / Triamcinolone Acetonide Pellet (100MG/20MCG), 1 PELLET (STERILE) (October 14, 2025)
  • D-0131-2026 Class II — Testosterone / Triamcinolone Acetonide 25MG/5MCG, 1 PELLET (STERILE) FOR SUBCUTA (October 14, 2025)
  • D-0132-2026 Class II — Testosterone / Triamcinolone Acetonide Pellet (37.5MG/7.5MCG), 1 PELLET (STERILE (October 14, 2025)
  • D-0134-2026 Class II — Testosterone / Triamcinolone Acetonide, 62.5MG/12.5MCG, 1 PELLET (STERILE) FOR S (October 14, 2025)